Differentiated Therapeutics (dx/tx) has built the first end-to-end discovery engine for Targeted Protein Degradation (TPD) which drives the discovery and optimization of novel protein degraders designed to eliminate the genetically defined drivers of disease
| Website | http://dxtherapeutics.com |
| Employees | 3 (2 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Clinical Development, Targeted Protein Degradation, New Drug Development, Drug Discovery, Therapeutic Development, Precision Medicine, Biotechnology, Pharmaceutical Research, Molecular Biology, Small Molecule Drugs, Oncology Therapeutics, Novel Therapeutics, Innovative Therapies, Pharmaceutical Innovation, Biopharmaceutical |
| Competitors | Amgen, Genentech, Novartis, Regeneron, Bristol Myers Squibb, Gilead Sciences, Pfizer, Lilly India, Merck & Co., Inc., Sanofi +46 more (view full list) |
Looking for a particular Differentiated Therapeutics employee's phone or email?
2 people are employed at Differentiated Therapeutics.
Differentiated Therapeutics is based in San Diego, California.